Top Suppliers:I want be here

82586-52-5

82586-52-5 structure
82586-52-5 structure
  • Name: Moexipril HCl
  • Chemical Name: (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid,hydrochloride
  • CAS Number: 82586-52-5
  • Molecular Formula: C27H35ClN2O7
  • Molecular Weight: 535.03
  • Catalog: Biochemical Inhibitor Endocrinology & Hormones RAAS inhibitor
  • Create Date: 2018-02-17 08:00:00
  • Modify Date: 2026-07-01 16:25:13
  • Moexipril HCl is a potent orally active non-sulfhydryl angiotensin converting enzyme(ACE) inhibitor, which is used for the treatment of hypertension and congestive heart failure. Target: ACEMoexipril is a long-acting ACE inhibitor suitable for once-daily administration, and like some ACE inhibitors, moexipril is a prodrug and needs to be hydrolyzed in the liver into its active carboxylic metabolite, moexiprilat, to become effective [1]. Upon oral administration of moexipril (10 mg/kg/day) to spontaneously hypertensive rats, plasma angiotensin II concentration decreased to undetectable levels, plasma ACE activity was inhibited by 98% and plasma angiotensin I concentration increased 8.6-fold 1 h after dosing. At 24 h, plasma angiotensin I and angiotensin II concentrations had returned to pretreatment levels, whereas plasma ACE activity was still inhibited by 56%. Four-week oral administration of moexipril (0.1-30 mg/kg/day) to spontaneously hypertensive rats lowered blood pressure and differentially inhibited ACE activity in plasma, lung, aorta, heart and kidney in a dose-dependent fashion [2, 3].

Name (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid,hydrochloride
Synonyms 2-[(2S)-2-[[(1S)-1-(Ethoxycbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecboxylicacidhydrochloride
Moexipril hydrochloride, >=
SPM-925
(S)-2-((S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-cboxylic acid hydrochloride
(3S)-2-[(2S)-2-[[(1S)-1-Ethoxycbonyl-3-Phenyl-Propyl]Amino]Propanoyl]-6,7-Dimethoxy-3,4-Dihydro-1H-Isoquinoline-3-Cboxylic Acid Hydrochloride
Moexipril HydrochlorideQ: What is Moexipril Hydrochloride Q: What is the CAS Number of Moexipril Hydrochloride Q: What is the storage condition of Moexipril Hydrochloride Q: What e the applications of Moexipril Hydrochloride
Moexipril HCl (RS-10085)
(3S)-2-[(2S)-2-[[(1S)-1-cbethoxy-3-phenyl-propyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-cboxylic acid hydrochloride
(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-cboxylic acid hydrochloride
Fempress
UNII-Q1UMG3UH45
(3S)- 2-[(2S)-2-[[(1S)-1-(ethoxycbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecboxylic acid,hydrochloride (1:1)
Moexipril HCl - Bio-X
SPM 925
Moexipril Hydrochloride
orally active,Apoptosis,Ischemic brain injury,inhibit,hatic disease,RS10085,Angiotensin-converting Enzyme (ACE),hydrochlorothiazide,essential hypertension,Moexipril hydrochloride,antihypertensive,moexiprilat,angiotensin II,cdiovasculdisease,RS 10085,Inhibitor,hypertension,Moexipril
2-[2-[[1-(ethoxycbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecboxylic acid, hydrochloride
(3S)-2-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan -2-yl]amino}propanoyl]-6,7-dimethoxy-1,2,3,4-tetr ahydroisoquinoline-3-cboxylic acid hydrochloride
RS-10085-197
MOEXIPRIL HYDROCHLORIDE //BP
Moexipril (hydrochloride)
Moexipril hydrochloride, 10 mM in DMSO
Moexipril HCL
3-Isoquinolinecboxylicacid,2-[(2S)-2-[[(1S)-1-(ethoxycbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-diMethoxy-,hydrochloride (1:1), (3S)
(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenyl-butan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-cboxylic acid hydrochloride
Univasc
(3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecboxylic Acid Hydrochloride
UNIVASC;RS10085;RS 10085;RS-10085
RS-10085
CI-925
MOEXIPRIL HYDROCHLORIDE
(3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycbonyl)-3-phenyl-d5-propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecboxylic Acid Hydrochloride
Perdix
Uniretic
Description Moexipril HCl is a potent orally active non-sulfhydryl angiotensin converting enzyme(ACE) inhibitor, which is used for the treatment of hypertension and congestive heart failure. Target: ACEMoexipril is a long-acting ACE inhibitor suitable for once-daily administration, and like some ACE inhibitors, moexipril is a prodrug and needs to be hydrolyzed in the liver into its active carboxylic metabolite, moexiprilat, to become effective [1]. Upon oral administration of moexipril (10 mg/kg/day) to spontaneously hypertensive rats, plasma angiotensin II concentration decreased to undetectable levels, plasma ACE activity was inhibited by 98% and plasma angiotensin I concentration increased 8.6-fold 1 h after dosing. At 24 h, plasma angiotensin I and angiotensin II concentrations had returned to pretreatment levels, whereas plasma ACE activity was still inhibited by 56%. Four-week oral administration of moexipril (0.1-30 mg/kg/day) to spontaneously hypertensive rats lowered blood pressure and differentially inhibited ACE activity in plasma, lung, aorta, heart and kidney in a dose-dependent fashion [2, 3].
Related Catalog
References

[1]. Chrysant, S.G. and G.S. Chrysant, Pharmacological and clinical profile of moexipril: a concise review. J Clin Pharmacol, 2004. 44(8): p. 827-36.

[2]. Edling, O., et al., Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril. J Pharmacol Exp Ther, 1995. 275(2): p. 854-63.

[3]. Song, J.C. and C.M. White, Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. Clin Pharmacokinet, 2002. 41(3): p. 207-24.

Boiling Point 709.3ºC at 760 mmHg
Melting Point 141-161ºC
Molecular Formula C27H35ClN2O7
Molecular Weight 535.03
Flash Point 382.8ºC
PSA 114.40000
LogP 3.71510
Storage condition 2-8°C
Symbol GHS09
GHS09
Signal Word Warning
Hazard Statements H400
Precautionary Statements P273
Personal Protective Equipment Eyeshields;Gloves
Hazard Codes N:Dangerous for the environment
Risk Phrases R50
Safety Phrases 60
RIDADR UN 3077
RTECS NW7174500
Precursor  1

DownStream  2

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.